Skip Navigation LinksHome   |   Reference Center   |   Publication List
  • Print
  • Share

CIBMTR Publication List

Since 1972, use of CIBMTR data and statistical resources have resulted in more than 1,000 publications. These publications are organized by year below, and can be searched to help you quickly find the information you need. 

Display:



2017

Year Title Authors Publication
2017 Allogeneic Hematopoietic Cell Transplantation for Aggressive NK-Cell Leukemia. A CIBMTR Analysis. Hamadani M, Kanate AS, DiGilio A, Woo Ahn K, Smith SM, Wook Lee J, Ayala E, Chao N, Hari P, Bolaños-Meade J, Gress R, Smedegaard Anderson N, Chen Y-B, Farooq U, Schiller G, Yared J, Sureda A, Fenske TS, Olteanu H Biol Blood Marrow Transplant
2017 The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia. Brunstein C, Zhang M-J, Barker J, St, Martin A, Bashey A, de Lima M, Dehn J, Hematti P, Perales MA, Rocha V, Territo M, Weisdorf D, Eapen M Haematologica
2017 Outcomes of UCB transplantation are comparable in FLT3+ AML: Results of CIBMTR, eurocord and EBMT collaborative analysis. Ustun C, Giannotti F, Zhang M-J, Wang H-L, Brunstein C, Labopin M, Rocha V, de Lima M, Baron F, Sandmaier B, Eapen M, Gluckman E, Nagler A, Weisdorf DJ, Ruggeri A Leukemia
2017 : Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis. Michelis FV, Gupta V, Zhang M-J, Wang H-L, Aljurf M, Bacher U, Beitinjaneh A, Chen Y-B, DeFilipp Z, Gale RP, Kebriaei P, Kharfan-Dabaja M, Lazarus HM, Nishihori T, Olsson RF, Oran B, Rashidi A, Rizzieri DA, Tallman MS, de Lima M, Khoury HJ, Sandmaier BM, Saber W Cancer
2017 Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission. Weisdorf DJ, Millard HR, Horowitz MM, Hyare PS, Champlin R, Ho V, Mielcarek M, Rezvani A, Stockerl-Goldstein K, Khoury HJ, de Lima M, Saber W, Sandmaier B, Zhang M-J, Eapen M Cancer
2017 Allogeneic hematopoietic cell transplant for adult chronic myelomonocytic leukemia. Liu HD, Ahn KW, Hu Z-H, Hamadani M, Nishihori T, Wirk B, Beitinjaneh A, Rizzieri D, Grunwald MR, Sabloff M, Olsson RF, Bajel A, Bredeson C, Daly A, Inamoto Y, Majhail N, Saad A, Gupta V, Gerds A, Malone A, Tallman M, Reshef R, Aljurf M, Marks DI, Copelan E, Gergis U, Savoie ML, Ustun C, Litzow MR, Cahn JY, Kindwell-Keller T, Akpek G, Savani BN, Rowe JM, Wiernik PH, Hsu JW, Cortes J, Kalaycio M, Maziarz R, Sobecks R, Popat U, Alyea E, Saber W Biol Blood Marrow Transplant
2017 The impact of pre-transplant depression on the outcomes of allogeneic and autologous hematopoietic stem cell transplantation. El-Jawahri A, Chen Y-B, Brazauskas R, He N, Lee SJ, Knight JM, Majhail N, Buchbinder D, Schears RM, Wirk BM, Wood WA, Ahmed I, Aljurf M, Szer J, Beattie SM, Battiwalla M, Dandoy C, Diaz M-A, D'Souza A, Freytes CO, Gajewski J, Gergis U, Hashmi SK, Jakubowski A, Kamble RT, Kindwell-Keller T, Lazarus HM, Malone AK, Marks DI, Meehan K, Savani BN, Olsson RF, Rizzieri D, Steinberg A, Speckhart D, Szwajcer D, Schoemans H, Seo S, Ustun C, Atsuta Y, Dalal J, Sales-Bonfim C, Khera N, Hahn T, Saber W Cancer
2017 Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT. Abu Zaid M, Wu J, Wu C, Logan BR, Yu J, Cutler C, Antin JH, Paczesny S, Choi SW Blood 129(2):162-170
2017 Instrumental variable with competing risk model. Zheng C, Dai R, Hari PN, Zhang M-J Stat Med
2017 Pre-transplant exercise and hematopoietic cell transplant Survival: a secondary analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902). Wingard J, Wood WA, Martens M, Le-Rademacher J, Logan B, Knight J, Jacobsen PB, Jim H, Majhail NS, Syrjala K, Rizzo JD, Lee S Biol Blood Marrow Transplant 23(1):161-164
2017 Recipient HLA-C haplotypes and miRNA 148a/b binding sites have no impact on allogeneic hematopoietic cell transplantation outcomes. Hoff GA, Fischer JC, Hsu K, Cooley S, Miller JS, Wang T, Haagenson M, Spellman S, Lee SJ, Uhrberg M, Venstrom JM, Verneris MR Biol Blood Marrow Transplant 23(1):153-160
2017 HRQoL among older related HSC donors (>60 yrs.) is equivalent to that of younger related donors (18-60 yrs.): An RDSafe study. Switzer GE, Bruce J, Kiefer DM, Kobusingye H, Drexler R, Besser RM, Confer DL, Horowitz MM, King RL, Shaw BE, Riches ML, Hayes-Lattin B, Linenberger M, Bolwell BJ, Rowley SD, Litzow MR, Pulsipher MA Biol Blood Marrow Transplant 23(1):165-171
2017 Novel HLA-DP region susceptibility loci associated with severe acute GvHD. Goyal RK, Lee SJ, Wang T, Trucco M, Haagenson M, Spellman SR, Veneris M, Ferrell RE Bone Marrow Transplant 52(1):95-100
2017 National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus recommendations for research methodology and study design. Shaw BE, Hahn T, Martin PJ, Mitchell S, Petersdorf EW, Armstrong GT, Shelburne N, Storer B, Bhatia S Biol Blood Marrow Transplant 23(1):10-23
2017 A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation. Magenau J, Westervelt P, Khaled S, McGuirk J, Hari P, Eapen M, Becker PS, Parkin B, Braun T, Logan B, Wang H, Jagasia M, Rowley SD, Kim DD, Schechter T, Frey N, Scott B, Churay T, Lieland S, Forman S, Mineishi S Bone Marrow Transplant 52(1):59-65
2017 Reduced Intensity Conditioned Allograft Yields Favorable Survival for Older Adults with B-cell Acute Lymphoblastic Leukemia: a CIBMTR Analysis. Rosko A, Wang H-L, de Lima M, Sandmaier B, Khoury HJ, Artz A, Brammer J, Bredeson C, Farag S, Kharfan-Dabaja MA, Lazarus HM, Marks DI, Martino Bufarull R, McGuirk J, Mohty M, Nishihori T, Nivison-Smith I, Rashidi A, Ringden O, Seftel M, Weisdorf D, Bachanova V, Saber W Am J Hematol 92(1):42-49
2017 Allogeneic transplantation for relapsed Waldenström macroglobulinemia and lymphoplasmacytic lymphoma. Cornell RF, Bachanova V, D'Souza A, Woo-Ahn K, Martens M, Huang J, Al-Homsi AS, Chhabra S, Copelan E, Diaz M-A, Freytes CO, Gale RP, Ganguly S, Hamadani M, Hildebrandt G, Kamble RT, Kharfan-Dabaja MA, Kindwall-Keller TL, Lazarus HM, Marks DI, Nishihori T, Olsson RF, Saad A, Usmani S, Vesole D, Yared J, Mark T, Nieto Y, Hari P Biol Blood Marrow Transplant 23(1):60-66
 
 
​​​​​

View current and planned studies
Last Updated: 3/23/2016 9:32 AM